uMed
uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process
uMed has raised €16M across 2 funding rounds from 4 investors, most recently a round in Jul 2023. Based in London, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€15,607,875
Funding rounds
2
Investors
4
distinct backers
Active since
2020-12
latest 2023-07
Funding by year
EUR raised per yearuMed — funding by year — interactive chart.
Data table
| uMed — funding by year | |
|---|---|
| 2020 | €4.1M |
| 2023 | €11M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-07-06 | Other | €11M | 11.2 Capital,AlbionVC,Delin Ventures,Playfair Capital | View deal → |
| 2020-12-02 | Other | €4.1M | AlbionVC | View deal → |